The expression of FABP6 and FABP9 in the control, BPH and carcinoma tissues was detected by immunohistochemical (IHC) staining and representative staining patterns are shown in Figure 2B and quantified in Table 1. This evidence concerns the gene FABP6 and benign prostatic hyperplasia.